Expression of cathepsin L and its inhibitor hurpin in inflammatory and neoplastic skin diseases

Experimental Dermatology

Volumn 15, Issue 2, 2006, Pages 110-118

  Bylaite, Markus ^a,b   Moussali, H ^a   Marciukaitiene, I ^b   Ruzicka, T ^a   Walz, M ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Cathepsin L; Hurpin; Immunohistochemistry; Inflammatory dermatoses; Neoplasias

Indexed keywords

CATHEPSIN L; HURPIN; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; CATHEPSIN; CYSTEINE PROTEINASE;

ACNE; ARTICLE; ATOPIC DERMATITIS; BASAL CELL CARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; EPIDERMIS; FOLLICULITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEG ULCER; LUPUS ERYTHEMATOSUS; MELANOMA; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSORIASIS; PYODERMA GANGRENOSUM; REFERENCE VALUE; SKIN INFLAMMATION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; DERMATITIS; DRUG ANTAGONISM; METABOLISM; PATHOLOGY; SKIN;

CARCINOMA, SQUAMOUS CELL; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; DERMATITIS; EPIDERMIS; HUMANS; IMMUNOHISTOCHEMISTRY; PSORIASIS; SERPINS; SKIN; SKIN NEOPLASMS;

EID: 33645128521     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2005.00389.x     Document Type: Article

References (52)

1. Dickinson D P. Cysteine peptidases of mammals: Their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med 2002: 13: 238-275.
2. Stoka V, Turk B, Schendel S L et al. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem 2001: 276: 3149-3157.
3. Turk B, Stoka V, Rozman-Pungercar J et al. Apoptotic pathways: involvement of lysosomal proteases. Biol Chem 2002: 383: 1035-1044.
4. McGrath M E. The lysosomal cysteine proteases. Annu Rev Biophys Biomol Struct 1999: 28: 181-204.
5. Nduwimana J, Guenet L, Dorval I et al. Proteases. Ann Biol Clin (Paris) 1995: 53: 251-264.
6. Toomes C, James J, Wood A J et al. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 1999: 23: 421-424.
7. Roth W, Deussing J, Botchkarev V A et al. Cathepsin L deficiency as molecular defect of furless: Hyperproliferation of keratinocytes and perturbation of hair follicle cycling. FASEB J 2000: 14: 2075-2086.
8. Chavanas S, Bodemer C, Rochat A et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000: 25: 141-142.
9. List K, Haudenschild C C, Szabo R et al. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 2002: 21: 3765-3779.
10. Nakagawa T, Roth W, Wong P et al. Cathepsin L. critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998: 280: 450-453.
11. Reinheckel T, Deussig J, Roth W, Peters C. Towards specific functions of lysosomal cysteine peptidases: Phenotype of mice deficient for cathepsin B or cathepsin L. Biol Chem 2001: 382: 735-741.
12. Honey K, Benlagha K, Beers C et al. Thymocyte expression of cathepsin L is essential for NKT cell development. Nat Immun 2002: 3: 1069-1074.
13. Kane S E, Gottesman M M. The role of cathepsin L in malignant transformation. Semin Cancer Biol 1990: 1: 127-136.
14. Ohashi K, Naruto M, Nakaki T, Sano E. Identification of interleukin-8 converting enzyme as cathepsin L. Biochim Biophys Acta 2003: 1649: 30 -39.-39.
15. Goretzki L, Schmitt M, Mann K et al. Effective activation of the proenzyme form of the urokinase-type plasminogen activator (uPA) by the cysteine protease cathepsin L. FEBS Lett 1992: 297: 112-118.
16. Chauhan S S, Goldstein L J, Gottesman M M. Expression of cathepsin L in human tumors. Cancer Res 1991: 51: 1478-1481.
17. Fröhlich E, Schlagenhauff B, Möhrle M, Weber E, Klessen C, Rassner G. Activity, expression and transcription rate of cathepsins B, D, H, and L in cutaneous malignant melanoma. Cancer 2001: 91: 972-982.
18. Sivaparvathi M, Yamamoto M, Nicolson G L et al. Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas. Clin Exp Metastasis 1996: 14: 27-34.
19. Dohchin A, Suzuki J I, Seki H, Masutani M, Shiroto H, Kawakami J. Immunostained cathepsins B and L correlated with depth of invasion and different metastatic pathways in early stage gastric carcinoma. Cancer 2000: 89: 482-487.
20. Kirschke H, Eerola R, Hopsu-Havu V K, Bromme D, Vuorio E. Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells. Eur J Cancer 2000: 36: 787-795.
21. Rousselet N, Mills L, Jean D, Tellez C, Bar-Eli M, Frade R. Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment. Cancer Res 2004: 64: 146-151.
22. Welss T, Sun J, Irving J A et al. Hurpin is a selective inhibitor of lysosomal cathepsin L and protects keratinocytes from ultraviolet-induced apoptosis. Biochemistry 2003: 42: 7381-7389.
23. Jayakumar A, Kang Y, Frederick M J et al. Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): A kinetic analysis. Arch Biochem Biophys 2003: 409: 367-374.
24. Abts H F, Welss T, Mirmohammadsadegh A R, Köhrer K, Michel G, Ruzicka T. Cloning and characterization of hurpin (protease inhibitor 13): A new skin-specific, UV-repressible serine proteinase inhibitor of the ovalbumin serpin family. J Mol Biol 1999: 293: 29-39.
25. Spring P, Nakashima T, Frederick M, Henderson Y, Clayman G. Identification and cDNA cloning of headpin, a novel differentially expressed serpin that maps to chromosome 18q. Biochem Biophys Res Commun 1999: 264: 299-304.
26. Moussali H, Bylaite M, Welss T, Abts H F, Ruzicka T, Walz M. Expression of hurpin, a serine proteinase inhibitor, in normal and pathological skin. overexpression and redistribution in psoriasis and cutaneous carcinomas. Exp Dermatol 2005: 14: 420-428.
27. Kawada A, Hara K, Kominami E et al. Processing of cathepsins L, B and D in psoriatic epidermis. Arch Dermatol Res 1997: 289: 87-93.
28. Palungwachira P, Kakuta M, Yamazaki M et al. Immunohistochemical localization of cathepsin L and cystatin A in normal skin and skin tumors. J Dermatol 2002: 29: 573-579.
29. Baird J, Lazarus G S, Vassali J D, Busso N, Gubler P, Jensen P J. mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. J Invest Dermatol 1990: 95: 548-552.
30. Sappino A P, Belin D, Huarte J, Hirschel-Scholz S, Saurat J H, Vassali J D. Differential protease expression by cutaneous squamous and basal cell carcinoma. J Clin Invest 1991: 88: 1073-1079.
31. Kuwae K, Matsumoto-Miyai K, Yoshida S et al. Epidermal expression of serine protease, neuropsin (KLK8) in normal and pathological skin samples. Mol Pathol 2002: 55: 235-241.
32. Silverman G A, Bird P I, Carrell R W et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 2001: 276: 33293-33296.
33. Cataltepe S, Gornstein E R, Schick C et al. Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas. J Histochem Cytochem 2000: 48: 113-122.
34. Zeeuwen P L, van Vlijmen-Willems I M, Egami H, Schalkwijk J. Cystatin M/ E expression in inflammatory and neoplastic skin disorders. Br J Dermatol 2002: 147: 87-94.
35. Bocock J P, Edgell C J S, Marr H S, Erickson A H. Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L. Eur J Biochem 2003: 270: 4008-4015.
36. Kato H. Expression and function of squamous cell carcinoma antigen. Anticancer Res 1996: 16: 2149-2153.
37. Pfundt R, van Ruissen F, van Vilijmen-Willems I M J J et al. Constitutive and inducible expression of SKALP/elafin provides anti-elastase defence in human epithelia. J Clin Invest 1996: 98: 1389-1399.
38. Scott F L, Paddle-Ledinek J E, Cerruti L, Coughlin P B, Salem H H, Bird P I. Proteinase inhibitor 6 (PI-6) expression in human skin: Induction of PI-6 and a PI-6/proteinase complex during keratinocyte differentiation. Exp Cell Res 1998: 245: 263-271.
39. Takeda A, Higuchi D, Takahashi T et al. Overexpression of serpin squamous cell carcinoma antigens in psoriatic skin. J Invest Dermatol 2002: 118: 147-154.
40. Kawashima K, Doi H, Ito Y, Shibata M A, Yoshinaka R, Otsuki Y. Evaluation of cell death and proliferation in psoriatic epidermis. J Dermatol Sci 2004: 35: 207-214.
41. Sakata Y, Arima K, Takai T et al. The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p 1. J Biol Chem 2004: 279: 5081-5087.
42. Wrone-Smith T, Mitra R S, Thompson C B, Jasty R, Castle V P, Nickoloff B J. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin. Am J Pathol 1997: 151: 1321-1329.
43. Friedrichs B, Tepel C, Reinheckel T et al. Thyroid functions of mouse cathepsins B, K, and L. J Clin Invest 2003: 111: 1733-1745.
44. Leist M, Jaattela M. Triggering of apoptosis by cathepsins. Cell Death Differ 2001: 8: 324-326.
45. Giustizieri M L, Mascia F, Frezzolini A et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol 2001: 107: 871-877.
46. Reis-Filho J S, Torio B, Albergaria A, Schmitt F C. Maspin expression in normal skin and usual cutaneous carcinomas. Virchows Arch 2002: 441: 551-558.
47. Barret A J, Kirschke H. Cathepsin B, cathepsin H, and cathepsin L. Methods Enzymol 1981: 80: 535-561.
48. Littlewood-Evans A J, Bilbe G, Bowler W B et al. The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res 1997: 57: 5386-5390.
49. Kos J, Stabuc B, Schweiger A, Krasovec M et al. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res 1997: 3: 1815-1822.
50. Stenman J, Hedstrom J, Grenman R et al. Relative levels of SCCA2 and SCCA1 mRNA in primary tumors predicts recurrent disease in squamous cell cancer of the head and neck. Int J Cancer 2001: 95: 39-43.
51. Thewes M, Engst R, Boeck K, Ring J. Expression of cathepsins in dermal fibrous tumors: An immunohistochemical study. Eur J Dermatol 1998: 8: 86-89.
52. Silverman G A, Bird P I, Carrell R W et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 2001: 276: 33293-33296.